A former White House adviser who pushed malaria drugs as a treatment for COVID-19 long after the FDA had ruled them out has ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines ...

While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...

HHS implemented a pause on research of deadly infectious diseases at one of the nation's most highly secure research labs, ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

The NIH plans to develop whole-virus vaccines that would provide universal immunity against all strains of influenza and COVID-19.

topping a previous award of $452 million to a company developing an experimental oral COVID-19 vaccine. An HHS spokesperson told CBS News that "decision-making for project Generation Gold Standard ...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal ...